In consideration of the side effects of non-selective COX-2 steroidal drugs, which are current clinical selections [9,10], it will be of great significance to investigate the COX-2 siRNA (siCOX-2) molecule that can selectively inhibit COX-2 expression by the gene silencing effect to suppress tumor growth. The gene discussed is PTGS2; the disease is neoplasm.